| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 17220-38-1 | 3,4-二氨基呋扎; 3,4-二氨基-1,2,5-惡二唑 | 3,4-Diaminofurazan; 3,4-Diamino-1,2,5-oxadiazole; Furazandiamine |  | C2H4N4O | 詳情 | 供應商 |
| 78350-50-2 | 3-氨基呋咱-4-羧酸; 4-氨基-1,2,5-惡二唑-3-羧酸 | 3-Aminofurazan-4-carboxylic acid; 4-Aminofurazan-3-carboxylic acid; 5-Aminofurazane-4-carboxylic acid; 4-Amino-1,2,5-oxadiazole-3-carboxylic acid |  | C3H3N3O3 | 詳情 | 供應商 |
| 588730-16-9 | N,4-二甲基-1,2,5-惡二唑-3-甲胺 | N,4-Dimethyl-1,2,5-oxadiazole-3-methanamine; 3-(Methylaminomethyl)-4-methylfurazan |  | C5H9N3O | 詳情 | 供應商 |
| 937174-76-0 | 4-[2-(4-氨基-1,2,5-惡二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-? | 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4; 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol; GSK 690693; (R)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-(PIPERIDIN-3-YLMETHOXY)-1H-IMI |  | C21H27N7O3 | 詳情 | 供應商 |
| 914471-09-3 | 4-氨基-N-(3-氯-4-氟苯基)-N'-羥基-1,2,5-惡二唑-3-甲脒; 4-氨基-N-(3-氯-4-氟苯基)-N'-羥基-1,2,5-惡二唑-3-甲脒 | indoleaMine-2,3-dioxygenase inhibitor INCB024360; INCB 024360; INCB024360; INCB-024360; INCB-24360; indoleaMine-2,3-dioxygenase inhibitor INCB024360; INCB024360/INCB-024360; 4-Amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide | 無 | C9H7ClFN5O2 | 詳情 | 供應商 |